Century Therapeutics (IPSC) Earnings Date & Reports
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IPSC is expected to report earnings to -37 cents per share on November 06
Q3'25
Est.
$-0.38
Q2'25
Est.
$-0.38
Q1'25
Beat
by $0.96
Q4'24
Est.
$-0.41
Q3'24
Beat
by $0.08
The last earnings report on August 14 showed earnings per share of -37 cents, meeting the estimate of -37 cents. With 784.56K shares outstanding, the current market capitalization sits at 48.40M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IPSC showed earnings on August 14, 2025. You can read more about the earnings report here.